•
Sep 30, 2013

AcelRx Q3 2013 Earnings Report

Total Revenue
$548K
Previous year: $166K
+230.1%
EPS
-$5.2
Previous year: -$7.6
-31.6%
Gross Profit
$548K
Previous year: $166K
+230.1%
Cash and Equivalents
$60.8M
Previous year: $3.72M
+1533.8%
Free Cash Flow
-$8.05M
Previous year: -$6.72M
+19.8%
Total Assets
$80.7M
Previous year: $28.2M
+186.5%

AcelRx

AcelRx